Safety and Effectiveness of an Investigational Agent (GM-611) in Patients With Diabetic Gastroparesis

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Gastroparesis
Interventions
DRUG

GM-611

Trial Locations (67)

13903

Diabetic Care Associates, Binghamton

15224

Keystone Digestive Disorders Consultants, PC, Pittsburgh

16153

Research Site, Stoneboro

17601

Regional Gastroenterology Associates of Lancaster, Lancaster

19107

Thomas Jefferson University, Philadelphia

19140

Temple University Hospital-GI Section, Philadelphia

20815

Chevy Chase Clinical Research, Chevy Chase

22031

Metropolitan Research, Fairfax

23249

McGuire VA Medical Center, Richmond

25301

Hyperion Clinical Research, Charleston

27103

Digestive Health Specialists, PA, Winston-Salem

28211

Carolina Digestive Health Associates, Charlotte

29118

Diabetes Control Center, Orangeburg

29425

Medical University of South Carolina, Charleston

33161

BioQuan Research Group, North Miami

33176

Baptist Diabetes Associates, Miami

33409

Palm Beach Research Center, West Palm Beach

34102

Anchor Research Center, Naples

34209

Gastroenterology Associates of Manatee, PA, Bradenton

34652

Suncoast Clinical Research, New Port Richey

38305

Regional Research Institute, Jackson

44195

Cleveland Clinic Foundation, Cleveland

45219

Consultants for Clinical Research, Cincinnati

46260

St. Vincent Hospital & Health Care Center, Indianapolis

48202

Henry Ford Hospital, Detroit

49503

Center for Diabetes & Endocrinology, Grand Rapids

53207

Wisconsin Center for Advanced Research, Milwaukee

55435

Radiant Research, Edina

60612

Rush Presbyterian St. Luke's Medical Center, Chicago

61107

Rockford Gastroenterology Associates, Ltd, Rockford

61602

Gastroenterology, Ltd., Peoria

66160

University of Kansas Medical Center, Kansas City

67203

Professional Research Network of Kansas, Wichita

70112

Tulane University Health Sciences Center, New Orleans

70458

Medical Research Institute, Slidell

73601

Prime Care Clinical Research, Clinton

75231

Radiant Research-Dallas North, Dallas

78224

Pro-Research Group, San Antonio

78229

Diabetes & Glandular Disease Research Associates, San Antonio

80002

Center for Diabetes & Endocrinology, Arvada

80262

Barbara Davis Center for Childhood Diabetes, Denver

83404

Rocky Mountain Institute of Clinical Research, Idaho Falls

83702

Idaho Gastroenterology Associates, Boise

83704

Radiant Research Boise, Boise

85016

Lovelace Scientific Resources, Phoenix

85306

Arizona Center for Clinical Research, Glendale

87108

Lovelace Scientific Resources, Inc, Albuquerque

89102

Lovelace Scientific Resources c/o Southwest Medical Associates, Las Vegas

90035

Research Foundation of America, Los Angeles

90630

Orange County Clinical Research, Inc, Cypress

90822

Long Beach VA Medical Center, Long Beach

91361

Westlake Medical Research, Westlake Village

92037

The Whittier Institute for Diabetes & Endocrinology, San Diego

92123

Sharp Rees-Stealy Medical Group, San Diego

92801

AGMG Clinical Research, Anaheim

92868

Community Clinical Trials, Orange

98034

Evergreen Diabetes & Endocrinology Medical Group, Kirkland

Unknown

Emory University School of Medicine, Atlanta

Digestive Health Center, University of Louisville, Louisville

GI Associates Research, Jackson

Pharma Tex Research, Amarillo

39216-9941

University of Mississippi Medical Center, Jackson

68198-2000

University of Nebraska Health Center, Omaha

03842

Core Health Services, Inc, Hampton

02911

Advanced Clinical Research, Ltd, North Providence

84132-2410

University of Utah Health Sciences Center, Salt Lake City

53717-2656

University of Wisconsin-Madison, Madison

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Chugai Pharma USA

INDUSTRY

NCT00050882 - Safety and Effectiveness of an Investigational Agent (GM-611) in Patients With Diabetic Gastroparesis | Biotech Hunter | Biotech Hunter